StonvexLoading…
StonvexStonvexStonvexCore line items from DLTH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-02-01 | Annual 2025 2025-02-02 | Annual 2024 2024-01-28 | Annual 2023 2023-01-29 |
|---|---|---|---|---|
Revenue | $565.18M | $626.63M | $646.68M | $653.31M |
Operating Income | $-10.16M | $-36.86M | $-9.57M | $6.23M |
Net Income | $-16.39M | $-43.67M | $-9.92M | $2.30M |
EPS (Diluted) | $-0.47 | $-1.31 | $-0.30 | $0.07 |
Total Assets | $402.61M | $452.44M | $491.21M | $527.45M |
Total Liabilities | $236.49M | $272.76M | $271.46M | $300.26M |
Cash & Equivalents | $16.34M | $3.33M | $32.16M | $45.55M |
Free Cash Flow OCF − CapEx | $16.57M | $-25.25M | $-10.41M | $-28.46M |
Shares Outstanding | 34.62M | 33.37M | 32.95M | 32.99M |